Author:
Kotosso Awèréou,Konu Yao Rodion,Bawe Lidaw Déassoua,Assenouwe Sarakawabalo,Tsevi Yawovi Mawufemo,Aziagbe Koffi Atsu,Patassi Akouda Akessiwe,Abaltou Bawoubadi,Tchamdja Gnimdou,Nebona Lampouguini,Adjoh Komi Séraphin,Ekouevi Didier,Wateba Majesté Ihou
Publisher
Scientific Research Publishing, Inc.
Reference28 articles.
1. WHO (December 2020) WHO Issues Its First Emergency Use Validation for a COVID-19 Vaccine and Emphasizes Need for Equitable Global Access. World Health Organization, Geneva.https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access.
2. Impact of prior vaccination with CovishieldTM and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study
3. Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID‐19
4. Africa Center for Strategic Studies (2021) Overcoming the Disparity in Africa’s COVID Vaccine Access. Spotlight, Washington.https://africacenter.org/spotlight/overcoming-the-disparity-in-africas-covid-vaccine/
5. World Health Organization African Region (2020) African Countries Engaging in Ground-Breaking COVID-19 Vaccine Initiative. WHO Africa, Brazzaville.https://www.afro.who.int/news/african-countries-engaging-ground-breaking-covid-19-vaccine-initiative